Dr.Nasser Alqahtani works for the first Central Health Cluster – Ministry Of Health (MOH) as an executive director for drug and pharmaceutical affairs and acting executive director for population health management directorate.

He is one of the Alfaisal University’s faculty members and works as an adjunct assistant professor of pharmacoepidemiology and Pharmacoeconomics

He used to serve as a director for drug safety and risk management dept at Saudi Food and Drug Authority (SFDA) for 13 consecutive years.

He receives his B.S. in Pharmacy from King Saud University, M.Sc. in clinical pharmacy from the UCL – UK and Ph.D. in pharmaceutical policy and outcomes research (Major: Pharmacoepidemiology) from Auburn University – Alabama, USA. He holds a certificate of higher diploma in pharmacovigilance and pharmacoepidemiology from London School of Hygiene and Tropical Medicine (LSHTM).

He is a member of a couple of professional societies: the International Society for Pharmacoepidemiology (ISPE), International Society of Pharmacovigilance (ISOP) International Society of pharmacoeconomics and outcomes research (ISPOR) American Association of Pharmaceutical Scientists (AAPS). Besides, he is a chairman of the national evidence-based practice committee at Saudi Health Council (SHC)